Serum creatine phosphokinase levels and prednisone treated muscle weakness
- 1 January 1977
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 27 (1) , 96
- https://doi.org/10.1212/wnl.27.1.96
Abstract
Evidence is cited from the literature and from personal experience with the “inflammatory” form of facioscapulohumeral syndrome that the creatine phosphokinase reduction occurring during pharmacologic treatment of various neuromuscular diseases does not necessarily imply therapeutic benefit.This publication has 1 reference indexed in Scilit:
- Hydrocortisone and/or desiccated thyroid in physiologic dosageMetabolism, 1964